BEAM
Price
$22.21
Change
+$1.61 (+7.82%)
Updated
Nov 21 closing price
Capitalization
2.25B
100 days until earnings call
Intraday BUY SELL Signals
MDXG
Price
$6.76
Change
+$0.21 (+3.21%)
Updated
Nov 21 closing price
Capitalization
1B
101 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BEAM vs MDXG

Header iconBEAM vs MDXG Comparison
Open Charts BEAM vs MDXGBanner chart's image
Beam Therapeutics
Price$22.21
Change+$1.61 (+7.82%)
Volume$1.95M
Capitalization2.25B
MiMedx Group
Price$6.76
Change+$0.21 (+3.21%)
Volume$836.84K
Capitalization1B
BEAM vs MDXG Comparison Chart in %
BEAM
Daily Signal:
Gain/Loss:
MDXG
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BEAM vs. MDXG commentary
Nov 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and MDXG is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 23, 2025
Stock price -- (BEAM: $22.21 vs. MDXG: $6.76)
Brand notoriety: BEAM and MDXG are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 80% vs. MDXG: 92%
Market capitalization -- BEAM: $2.25B vs. MDXG: $1B
BEAM [@Biotechnology] is valued at $2.25B. MDXG’s [@Biotechnology] market capitalization is $1B. The market cap for tickers in the [@Biotechnology] industry ranges from $108.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileMDXG’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • MDXG’s FA Score: 1 green, 4 red.
According to our system of comparison, MDXG is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while MDXG’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 7 bearish.
  • MDXG’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, MDXG is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +2.26% price change this week, while MDXG (@Biotechnology) price change was -8.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.01%. For the same industry, the average monthly price growth was -3.31%, and the average quarterly price growth was +62.87%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 03, 2026.

MDXG is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (-1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.25B) has a higher market cap than MDXG($1B). BEAM YTD gains are higher at: -10.444 vs. MDXG (-29.730). MDXG has higher annual earnings (EBITDA): 68.3M vs. BEAM (-414.33M). BEAM has more cash in the bank: 1.15B vs. MDXG (142M). MDXG has less debt than BEAM: MDXG (18.2M) vs BEAM (155M). MDXG has higher revenues than BEAM: MDXG (393M) vs BEAM (60.3M).
BEAMMDXGBEAM / MDXG
Capitalization2.25B1B225%
EBITDA-414.33M68.3M-607%
Gain YTD-10.444-29.73035%
P/E RatioN/A25.04-
Revenue60.3M393M15%
Total Cash1.15B142M810%
Total Debt155M18.2M852%
FUNDAMENTALS RATINGS
MDXG: Fundamental Ratings
MDXG
OUTLOOK RATING
1..100
93
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
92
SMR RATING
1..100
45
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
11
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMMDXG
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 4 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signal:
Gain/Loss:
MDXG
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FGEMX133.302.31
+1.76%
Fidelity Advisor Communication ServicesM
MWOFX64.351.04
+1.64%
MFS Global Growth A
VSGEX7.350.10
+1.38%
Virtus SGA International Growth C
RMOYX25.160.30
+1.21%
Victory RS Mid Cap Growth Y
PAWAX78.410.71
+0.91%
T. Rowe Price All-Cap Opportunities-Adv